Leber's Hereditary Optic Neuropathy-Gene Therapy: From Benchtop to Bedside
2011
Gene Therapy for Leber's Hereditary Optic Neuropathy
publication
Evidence: moderate
Author Information
Author(s): Koilkonda Rajeshwari D., Guy John
Primary Institution: Bascom Palmer Eye Institute, University of Miami
Hypothesis
Can gene therapy effectively treat Leber's hereditary optic neuropathy (LHON)?
Conclusion
Gene therapy shows promise in restoring vision in patients with LHON caused by specific mitochondrial mutations.
Supporting Evidence
- Gene therapy has been shown to increase ATP synthesis in LHON cell lines.
- Animal models have demonstrated that allotopic expression of the ND4 gene can prevent vision loss.
- Clinical trials are ongoing to evaluate the safety and efficacy of gene therapy for LHON.
Takeaway
Leber's hereditary optic neuropathy is a genetic condition that can cause blindness, but scientists are working on gene therapy to help people see again.
Methodology
The paper reviews various studies and discusses potential gene therapy strategies for LHON.
Limitations
The effectiveness of current therapies is still under investigation, and results may vary among patients.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website